20-383 - ALTE11C2 - Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer TreatmentStatus: open
ALTE11C2 - Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
Observational study to learn about effects of dexrazoxane hydrochloride
This clinical trial studies the effects of dexrazoxane hydrochloride on biomarkers associated with cardiomyopathy and heart failure after cancer treatment. Studying samples of blood in the laboratory from patients receiving dexrazoxane hydrochloride may help doctors learn more about the effects of dexrazoxane hydrochloride on cells. It may also help doctors understand how well patients respond to treatment
SponsorsThis trial is sponsored by Children's Oncology Group.
Interested in Clinical Trial?
Providers Associated With This Trial
- Hamayun Imran, M.D.Pediatric Hematologist/OncologistProfessor of Pediatrics
- Preethi Marri, M.D.Pediatric Hematology and OncologyAssistant Professor of Pediatrics
- Chibuzo Ilonze, M.D., M.P.H.Pediatric Hematologist/OncologistAssistant Professor of Pediatric Hematology/Oncology